Table 3 summarizes the comparison of EVs between the non-coagulopathy and coagulopathy groups. No difference was found in the EV levels between the two groups, despite the higher proportion of patients in the COVID-19 coagulopathy group who had higher CD41+ EV levels than those in the COVID-19 non-coagulopathy group (Figure 3). Here, ITGA2B is linked to blood coagulation disease.